Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Evaluating the Effectiveness of Tofacitinib in Systemic Sclerosis

NCT06044844 is registered in ClinicalTrials.gov with Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh as lead sponsor.

NCT NCT06044844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06044844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Evaluating the Effectiveness of Tofacitinib in Systemic Sclerosis
Lead sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2023
Completion date
May 31, 2024
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

efficacy of tofacitinib in the systemic sclerosis